T his 59-year-old man with no other comorbidities presented with a 5-month history of exertional dyspnea and a 2-month history of peripheral edema. Chest radiography revealed bilateral pleural effusions. Subsequent computed tomography of the thorax (Fig 1) showed an anterior mediastinal mass with invasion into the SVC and innominate veins; it had infiltrated the heart occupying the entire right atrial and ventricular chambers. Panel A shows the 6.1-cm anterior mediastinal mass with SVC invasion. Panel B shows obliteration of the right atrial and ventricular chambers. Panel C shows an echocardiographic representation of the mass within the right heart (A ¼ aorta; E ¼ pleural effusion; LV ¼ left ventricle; RA ¼ right atrium; RV ¼ right ventricle; SVC ¼ superior vena cava; T ¼ tumor).
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